MARKET CLOSE: NZ shares rise on international vaccine excitement

Dan Brunskill
Tue, 19 May 2020

New Zealand shares followed Wall Street higher as investors were encouraged by positive data from a small covid-19 vaccine trial.   The S&P/NZX 50 Index rose 32.20 points, or 0.3 percent, to 10,790.14. Within the index, 35 stocks rose, eight fell and seven were unchanged. Turnover was $124.8 million. Data from a study of eight healthy adults suggested a vaccine under development by American biotechnology company, Moderna Inc, is safe and produces antibodies which fend off the virus. The data is a hopeful sign, but a doctor from Johns H...
JEHAN CASINADER: Black lives matter – but changing your Facebook photo does not
Jehan Casinader | Sat, 06 Jun 2020

My Facebook timeline is a sea of black.  During the week, many of my friends posted photos of empty black squares, to express their anger at the brutal killing of Minneapolis man George Floyd.The idea...

Is the art market covid-proof? Well, just maybe
Pattrick Smellie | Sat, 06 Jun 2020

Wellington art auction house Dunbar Sloane marked the end of an era this week, bringing the hammer down - or in this case, an HB pencil clasped in the left hand of veteran auctioneer Anthony Gallagher...

Listed Companies
BRIAN GAYNOR: Colin Neal – taking the NZX by storm
Brian Gaynor | Fri, 05 Jun 2020

Who is Colin Neal, the former Big Chill owner who sold out to Freightways and is now charging like a bull through the NZX? Neal has gone from refrigerated transport to brewing and restaurants to st...

Telcos in lockdown, and beyond

Geoff Thorn, CEO, NZ Telecommunications Forum says modern connectivity was a major benefit during lockdown, so it’s important to ensure long term sustainability of the networks

Profit or Loss: The Dangers of Fake ROI

It's hard to know what is going to happen in the future. This virus and its effects are changing everything, so businesses need to take a careful look at their marketing.